Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis

Eric N Ouattara, Rachel L MacLean, Christine Danel, Ethan D Borre, Delphine Gabillard, Mingshu Huang, Raoul Moh, A David Paltiel, Serge P Eholié, Rochelle P Walensky, Xavier Anglaret and Kenneth A Freedberg

PLOS ONE, 2019, vol. 14, issue 6, 1-16

Abstract: Introduction: The Temprano and START trials provided evidence to support early ART initiation recommendations. We projected long-term clinical and economic outcomes of immediate ART initiation in Côte d’Ivoire. Methods: We used a mathematical model to compare three potential ART initiation criteria: 1) CD4

Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0219068 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 19068&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0219068

DOI: 10.1371/journal.pone.0219068

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().